Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03892044
Title Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jennifer Woyach
Indications

Richter's syndrome

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Duvelisib + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.